PortfoliosLab logo

Bellerophon Therapeutics, Inc. (BLPH)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Bellerophon Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $481 for a total return of roughly -95.19%. All prices are adjusted for splits and dividends.

BLPH (Bellerophon Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BLPH

Bellerophon Therapeutics, Inc.


Bellerophon Therapeutics, Inc. had a return of 618.89% year-to-date (YTD) and 249.73% in the last 12 months. Over the past 10 years, Bellerophon Therapeutics, Inc. had an annualized return of -31.31%, while the S&P 500 had an annualized return of 8.04%, indicating that Bellerophon Therapeutics, Inc. did not perform as well as the benchmark.

1 month331.33%-5.31%
6 months401.55%0.39%
1 year249.73%-10.12%
5 years (annualized)-26.14%7.32%
10 years (annualized)-31.31%8.04%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Bellerophon Therapeutics, Inc. Sharpe ratio is 1.15. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.

BLPH (Bellerophon Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History

Bellerophon Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BLPH (Bellerophon Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Bellerophon Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Bellerophon Therapeutics, Inc. is 99.63%, recorded on Dec 20, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.63%Mar 2, 20151968Dec 20, 2022
-2.29%Feb 24, 20151Feb 24, 20152Feb 26, 20153

Volatility Chart

Current Bellerophon Therapeutics, Inc. volatility is 211.52%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BLPH (Bellerophon Therapeutics, Inc.)
Benchmark (^GSPC)